News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
PharmaFrontiers Appoints David B. McWilliams CEO; Brian E. Rodriguez Named Director, Head Of Audit Committee
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Adult stem cell therapy developer PharmaFrontiers Corp. (OTCBB:PFTR) has appointed David B. McWilliams as the company's chief executive officer.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Manufacturing
Viatris recalls extended-release Xanax over dissolution test failure
April 20, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
April 20, 2026
·
2 min read
·
Annalee Armstrong
Cell therapy
Agenus cancer cocktail records 0% response rate, missing midstage goal
April 20, 2026
·
2 min read
·
Gabrielle Masson
IPO tracker
Odyssey tests IPO waters anew after quitting quest last year
April 20, 2026
·
10 min read
·
Tristan Manalac